SCHEMBL5651991

SCHEMBL5651991

O=C(c1ccc(Cl)cc1)c1ccc(OC(=O)N2CCCCC2)cc1

nearest known ligand 0.85

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.73
KMT2A Q03164 5/20 0.73
NPC1 O15118 4/20 0.73
POLB P06746 2/20 0.70
ALDH1A1 P00352 2/20 0.70
SMN1; SMN2 Q16637 4/20 0.57
LMNA P02545 2/20 0.57
NPSR1 Q6W5P4 1/20 0.57
MAPT P10636 5/20 0.56
RAB9A P51151 4/20 0.56
HTT P42858 2/20 0.56
LIPE Q05469 3/20 0.52
HPGD P15428 2/20 0.52
TSHR P16473 1/20 0.52
ELANE P08246 1/20 0.51
ATM Q13315 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27517703 0.92 ALDH1A1 (0.82) MEN1KMT2ANPC1POLBALDH1A1
SCHEMBL10974361 0.91 POLB (0.79) MEN1KMT2ANPC1POLBALDH1A1
SCHEMBL5649459 0.85 KMT2A (0.77) MEN1KMT2ANPC1ALDH1A1SMN1; SMN2
SCHEMBL5648758 0.84 POLB (0.68) MEN1KMT2ANPC1POLBALDH1A1
SCHEMBL5651420 0.81 ALDH1A1 (0.64) MEN1KMT2ANPC1POLBALDH1A1
SCHEMBL27651688 0.79 ALDH1A1 (0.76) MEN1KMT2ANPC1POLBALDH1A1
SCHEMBL5646336 0.76 LIPE (0.61) MEN1KMT2APOLBALDH1A1MAPT
SCHEMBL27627299 0.76 ALDH1A1 (0.56) MEN1KMT2ANPC1POLBALDH1A1
SCHEMBL5426177 0.76 ALDH1A1 (0.56) MEN1KMT2ANPC1POLBALDH1A1
SCHEMBL22221468 0.76 PPARA (0.62) MEN1KMT2ANPC1POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2003-09-04 US claimed
US-7279470-B2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2007-10-09 US disclosed
US-7067517-B2 Use of compounds for decreasing activity of hormone-sensitive lipase NERO NORDISK A/S (DK) 2006-06-27 US disclosed
EP-1458374-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
WO-2003051841-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase LIPE, PNLIP, LPL MEN1 2277/4885KMT2A 4150/4885NPC1 814/4885
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive LIPE, PNLIP, LPL MEN1 1767/4885KMT2A 4322/4885NPC1 973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.